Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	nuclear receptor coactivator activity	TRERF1 NCOA3 DCAF6 ZMIZ2 RBM14	8.11e-06	61	90	5	GO:0030374
GeneOntologyMolecularFunction	neurexin family protein binding	NLGN4X NLGN4Y NLGN2	4.75e-05	16	90	3	GO:0042043
GeneOntologyMolecularFunction	transcription coactivator activity	TRERF1 NCOA3 DCAF6 ZMIZ2 RBM14 FUS ARID1A	4.41e-04	303	90	7	GO:0003713
GeneOntologyMolecularFunction	chromatin binding	EBF2 SOX2 NCOA3 TLE4 FOSL2 FUS RUNX1 ARID1A ADNP RPA1 STAT5B	4.82e-04	739	90	11	GO:0003682
GeneOntologyMolecularFunction	neutral L-amino acid:sodium symporter activity	SLC38A2 SLC38A3	5.53e-04	8	90	2	GO:0005295
GeneOntologyMolecularFunction	L-glutamine transmembrane transporter activity	SLC38A2 SLC38A3	7.09e-04	9	90	2	GO:0015186
GeneOntologyMolecularFunction	DNA-binding transcription activator activity, RNA polymerase II-specific	EBF2 SOX2 NCOA3 LHX4 PAX8 FOSL2 POU3F2 RUNX1 STAT5B	9.46e-04	560	90	9	GO:0001228
GeneOntologyMolecularFunction	transcription coregulator activity	TRERF1 NCOA3 DCAF6 TLE4 ZMIZ2 RBM14 TAF15 FUS ARID1A	9.70e-04	562	90	9	GO:0003712
GeneOntologyMolecularFunction	DNA-binding transcription activator activity	EBF2 SOX2 NCOA3 LHX4 PAX8 FOSL2 POU3F2 RUNX1 STAT5B	1.02e-03	566	90	9	GO:0001216
GeneOntologyBiologicalProcess	presynaptic membrane assembly	NLGN4X NLGN4Y NLGN2	9.75e-06	10	91	3	GO:0097105
GeneOntologyBiologicalProcess	postsynaptic membrane assembly	NLGN4X NLGN4Y NLGN2	1.34e-05	11	91	3	GO:0097104
GeneOntologyBiologicalProcess	presynaptic membrane organization	NLGN4X NLGN4Y NLGN2	2.30e-05	13	91	3	GO:0097090
GeneOntologyBiologicalProcess	neuron cell-cell adhesion	NLGN4X NLGN4Y NLGN2	4.46e-05	16	91	3	GO:0007158
GeneOntologyBiologicalProcess	territorial aggressive behavior	NLGN4X NLGN4Y	5.76e-05	3	91	2	GO:0002124
GeneOntologyBiologicalProcess	male courtship behavior	NLGN4X NLGN4Y	1.15e-04	4	91	2	GO:0008049
GeneOntologyCellularComponent	symmetric, GABA-ergic, inhibitory synapse	NLGN4X NLGN4Y NLGN2	3.18e-07	4	91	3	GO:0098983
GeneOntologyCellularComponent	transcription regulator complex	TRERF1 SOX2 NCOA3 PAX8 TLE4 FOSL2 RBM14 POU3F2 RUNX1 ADNP RFX3 STAT5B	1.05e-05	596	91	12	GO:0005667
GeneOntologyCellularComponent	symmetric synapse	NLGN4X NLGN4Y NLGN2	2.21e-05	13	91	3	GO:0032280
GeneOntologyCellularComponent	glycinergic synapse	NLGN4X NLGN4Y NLGN2	8.62e-05	20	91	3	GO:0098690
GeneOntologyCellularComponent	inhibitory synapse	NLGN4X NLGN4Y NLGN2	3.28e-04	31	91	3	GO:0060077
GeneOntologyCellularComponent	dendrite	GABRD SLC38A2 KLHL1 NLGN4X NLGN4Y ACAD9 KIF21A CPEB4 NLGN2 FUS ADNP CAPRIN1	3.39e-04	858	91	12	GO:0030425
GeneOntologyCellularComponent	dendritic tree	GABRD SLC38A2 KLHL1 NLGN4X NLGN4Y ACAD9 KIF21A CPEB4 NLGN2 FUS ADNP CAPRIN1	3.46e-04	860	91	12	GO:0097447
GeneOntologyCellularComponent	axon	GABRD SLC38A2 MYCBP2 KIF21A CPEB4 KCNQ2 ROBO2 NLGN2 ADAM11 GPRIN1 ADNP ALK	4.76e-04	891	91	12	GO:0030424
GeneOntologyCellularComponent	GABA-ergic synapse	GABRD NLGN4X NLGN4Y NLGN2 FUS	7.55e-04	164	91	5	GO:0098982
GeneOntologyCellularComponent	RNA polymerase II transcription regulator complex	NCOA3 TLE4 FOSL2 RUNX1 ADNP STAT5B	1.22e-03	272	91	6	GO:0090575
GeneOntologyCellularComponent	chromatin	EBF2 SOX2 NCOA3 LHX4 PAX8 FOSL2 ZMIZ2 ZBTB5 POU3F2 INO80 RUNX1 ARID1A ADNP RFX3 STAT5B	1.74e-03	1480	91	15	GO:0000785
MousePheno	perinatal lethality	SOX2 SLC38A2 ZBTB20 LHX4 MYCBP2 FMN1 KIF21A MTM1 CPEB4 RANBP9 KCNQ2 ROBO2 FUS RUNX1 ARID1A RFX3 HECTD1 CAPRIN1 ALK	5.48e-06	1130	75	19	MP:0002081
MousePheno	postnatal growth retardation	EBF2 TGFBI NCOA3 ZBTB20 PAX8 TLE4 FOSL2 MTM1 RANBP9 POU3F2 FUS RUNX1 RFX3 CTSK ALK AXIN2	1.37e-05	881	75	16	MP:0001732
MousePheno	abnormal cell differentiation	EBF2 SOX2 NCOA3 ZBTB20 MYCBP2 FOSL2 CPEB4 RANBP9 PRKCD ROBO2 RUNX1 PMEPA1 DKK2 WDR62 AXIN2	1.71e-05	795	75	15	MP:0005076
MousePheno	abnormal postnatal growth	EBF2 TGFBI NCOA3 ZBTB20 PAX8 TLE4 FOSL2 MTM1 RANBP9 POU3F2 FUS RUNX1 RFX3 CTSK ALK AXIN2	1.97e-05	907	75	16	MP:0001731
MousePheno	abnormal epiphyseal plate morphology	EBF2 PAX8 TLE4 FOSL2 ACP5 PRKCD CTSK	5.90e-05	185	75	7	MP:0006395
MousePheno	abnormal skeleton development	EBF2 PAX8 TLE4 FOSL2 ACP5 PRKCD PMEPA1 CTSK DKK2 AXIN2	1.30e-04	447	75	10	MP:0002113
Domain	Nlgn	NLGN4X NLGN4Y NLGN2	9.70e-07	5	87	3	IPR000460
Domain	-	TAF15 FUS ZRANB1	1.14e-05	10	87	3	4.10.1060.10
Domain	NLGN4	NLGN4X NLGN4Y	2.14e-05	2	87	2	IPR030025
Domain	Carboxylesterase_B_CS	NLGN4X NLGN4Y NLGN2	2.70e-05	13	87	3	IPR019819
Domain	CARBOXYLESTERASE_B_2	NLGN4X NLGN4Y NLGN2	3.42e-05	14	87	3	PS00941
Domain	COesterase	NLGN4X NLGN4Y NLGN2	3.42e-05	14	87	3	PF00135
Domain	CarbesteraseB	NLGN4X NLGN4Y NLGN2	3.42e-05	14	87	3	IPR002018
Domain	zf-RanBP	TAF15 FUS ZRANB1	1.41e-04	22	87	3	PF00641
Domain	ZnF_RBZ	TAF15 FUS ZRANB1	1.62e-04	23	87	3	SM00547
Domain	ZF_RANBP2_2	TAF15 FUS ZRANB1	1.62e-04	23	87	3	PS50199
Domain	ZF_RANBP2_1	TAF15 FUS ZRANB1	1.84e-04	24	87	3	PS01358
Domain	Znf_RanBP2	TAF15 FUS ZRANB1	2.08e-04	25	87	3	IPR001876
Domain	FH2	FMN1 FHDC1	2.17e-03	15	87	2	PS51444
Domain	FH2_Formin	FMN1 FHDC1	2.17e-03	15	87	2	IPR015425
Domain	FH2	FMN1 FHDC1	2.17e-03	15	87	2	PF02181
Domain	FH2	FMN1 FHDC1	2.17e-03	15	87	2	SM00498
Domain	Aa_trans	SLC38A2 SLC38A3	2.79e-03	17	87	2	PF01490
Domain	AA_transpt_TM	SLC38A2 SLC38A3	2.79e-03	17	87	2	IPR013057
Domain	Prefoldin	KRT24 TLE4 KIF21A	4.62e-03	72	87	3	IPR009053
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	GABRD DCAF6 MYCBP2 KIF21A MTM1 DDX18 RANBP9 NAV3 ZBTB5 KCNQ2 USP54 RUNX1 ARID1A HECTD1 CAPRIN1 STAT5B JPH3 CUEDC1	5.37e-09	1285	91	18	35914814
Pubmed	Neuroligin-4 is localized to glycinergic postsynapses and regulates inhibition in the retina.	NLGN4X NLGN4Y NLGN2	1.73e-08	3	91	3	21282647
Pubmed	Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism.	NLGN4X NLGN4Y NLGN2	6.92e-08	4	91	3	12669065
Pubmed	Homodimerization and isoform-specific heterodimerization of neuroligins.	NLGN4X NLGN4Y NLGN2	6.92e-08	4	91	3	22671294
Pubmed	Multiple N-linked glycosylation sites critically modulate the synaptic abundance of neuroligin isoforms.	NLGN4X NLGN4Y NLGN2	1.73e-07	5	91	3	37865312
Pubmed	Synapse formation: if it looks like a duck and quacks like a duck ...	NLGN4X NLGN4Y NLGN2	1.73e-07	5	91	3	10996085
Pubmed	The synaptic protein neuroligin-1 interacts with the amyloid β-peptide. Is there a role in Alzheimer's disease?	NLGN4X NLGN4Y NLGN2	3.45e-07	6	91	3	21838267
Pubmed	Autism-associated neuroligin-4 mutation selectively impairs glycinergic synaptic transmission in mouse brainstem synapses.	NLGN4X NLGN4Y NLGN2	3.45e-07	6	91	3	29724786
Pubmed	SNX27-driven membrane localisation of OTULIN antagonises linear ubiquitination and NF-κB signalling activation.	TGFBI DCAF6 NLGN4X MTM1 RANBP9 ZBTB5 NLGN2 FUS ARID1A	6.88e-07	378	91	9	34315543
Pubmed	Human transcription factor protein interaction networks.	TRERF1 SOX2 NCOA3 LIPT1 LHX4 PAX8 TLE4 ZMIZ2 DDX18 INO80 USP54 ARID1A ADNP RPA1 CAPRIN1 STAT5B	8.62e-07	1429	91	16	35140242
Pubmed	Identification of methylated proteins by protein arginine N-methyltransferase 1, PRMT1, with a new expression cloning strategy.	TAF15 FUS CAPRIN1	9.61e-07	8	91	3	12183049
Pubmed	Neuroligin-1 Signaling Controls LTP and NMDA Receptors by Distinct Molecular Pathways.	NLGN4X NLGN4Y NLGN2	9.61e-07	8	91	3	30871858
Pubmed	Role of Elavl-like RNA-binding protein in retinal development and signal transduction.	SOX2 NLGN4X NLGN4Y NLGN2	1.31e-06	31	91	4	39307290
Pubmed	Development, maturation, and necessity of transcription factors in the mouse suprachiasmatic nucleus.	SOX2 LHX4 CSRP2 POU3F2 RFX3	1.87e-06	77	91	5	21525287
Pubmed	Temporal patterning of apical progenitors and their daughter neurons in the developing neocortex.	SOX2 ZBTB20 TLE4 ROBO2 POU3F2	2.55e-06	82	91	5	31073041
Pubmed	Epidermal progenitors suppress GRHL3-mediated differentiation through intronic polyadenylation promoted by CPSF-HNRNPA3 collaboration.	RBM14 TAF15 FUS	2.82e-06	11	91	3	33469008
Pubmed	SPARCL1 Promotes Excitatory But Not Inhibitory Synapse Formation and Function Independent of Neurexins and Neuroligins.	NLGN4X NLGN4Y NLGN2	2.82e-06	11	91	3	32973045
Pubmed	Behavioral phenotypes of genetic mouse models of autism.	NLGN4X NLGN4Y NLGN2	2.82e-06	11	91	3	26403076
Pubmed	An Oct4-centered protein interaction network in embryonic stem cells.	SOX2 NCOA3 RBM14 ARID1A ADNP RPA1	5.33e-06	167	91	6	20362541
Pubmed	Epigenomic Profiling Discovers Trans-lineage SOX2 Partnerships Driving Tumor Heterogeneity in Lung Squamous Cell Carcinoma.	SOX2 POU3F2	6.77e-06	2	91	2	31551362
Pubmed	Development of an autism severity score for mice using Nlgn4 null mutants as a construct-valid model of heritable monogenic autism.	NLGN4X NLGN4Y	6.77e-06	2	91	2	23183221
Pubmed	Juvenile manifestation of ultrasound communication deficits in the neuroligin-4 null mutant mouse model of autism.	NLGN4X NLGN4Y	6.77e-06	2	91	2	24855039
Pubmed	Sex-specific microglia state in the Neuroligin-4 knock-out mouse model of autism spectrum disorder.	NLGN4X NLGN4Y	6.77e-06	2	91	2	37001827
Pubmed	Runt-related transcription factor 1 contributes to lung cancer development by binding to tartrate-resistant acid phosphatase 5.	ACP5 RUNX1	6.77e-06	2	91	2	31650885
Pubmed	Expression of tartrate-resistant acid phosphatase and cathepsin K during osteoclast differentiation in developing mouse mandibles.	ACP5 CTSK	6.77e-06	2	91	2	33563875
Pubmed	Characterization of LILRB3 and LILRA6 allelic variants in the Japanese population.	LILRB3 LILRA6	6.77e-06	2	91	2	33526815
Pubmed	Distinct frequency patterns of LILRB3 and LILRA6 allelic variants in Europeans.	LILRB3 LILRA6	6.77e-06	2	91	2	36449053
Pubmed	Conditional Knockout of PKC-δ in Osteoclasts Favors Bone Mass Accrual in Males Due to Decreased Osteoclast Function.	PRKCD CTSK	6.77e-06	2	91	2	32582715
Pubmed	Unusually rapid evolution of Neuroligin-4 in mice.	NLGN4X NLGN4Y	6.77e-06	2	91	2	18434543
Pubmed	Genomic structure of the human RBP56/hTAFII68 and FUS/TLS genes.	TAF15 FUS	6.77e-06	2	91	2	9795213
Pubmed	Pain prediction by serum biomarkers of bone turnover in people with knee osteoarthritis: an observational study of TRAcP5b and cathepsin K in OA.	ACP5 CTSK	6.77e-06	2	91	2	28087412
Pubmed	Increased Network Inhibition in the Dentate Gyrus of Adult Neuroligin-4 Knock-Out Mice.	NLGN4X NLGN4Y	6.77e-06	2	91	2	37080762
Pubmed	Allogeneic disparities in immunoglobulin-like transcript 5 induce potent antibody responses in hematopoietic stem cell transplant recipients.	LILRB3 LILRA6	6.77e-06	2	91	2	19617579
Pubmed	Autism Related Neuroligin-4 Knockout Impairs Intracortical Processing but not Sensory Inputs in Mouse Barrel Cortex.	NLGN4X NLGN4Y	6.77e-06	2	91	2	29106499
Pubmed	Perturbed Hippocampal Synaptic Inhibition and γ-Oscillations in a Neuroligin-4 Knockout Mouse Model of Autism.	NLGN4X NLGN4Y	6.77e-06	2	91	2	26456829
Pubmed	Nlgn4 knockout induces network hypo-excitability in juvenile mouse somatosensory cortex in vitro.	NLGN4X NLGN4Y	6.77e-06	2	91	2	24104404
Pubmed	A Cluster of Autism-Associated Variants on X-Linked NLGN4X Functionally Resemble NLGN4Y.	NLGN4X NLGN4Y	6.77e-06	2	91	2	32243781
Pubmed	Absence of deficits in social behaviors and ultrasonic vocalizations in later generations of mice lacking neuroligin4.	NLGN4X NLGN4Y	6.77e-06	2	91	2	22989184
Pubmed	The E3 ubiquitin ligase Mycbp2 genetically interacts with Robo2 to modulate axon guidance in the mouse olfactory system.	MYCBP2 ROBO2	6.77e-06	2	91	2	23525682
Pubmed	Diversity of the human LILRB3/A6 locus encoding a myeloid inhibitory and activating receptor pair.	LILRB3 LILRA6	6.77e-06	2	91	2	24096970
Pubmed	Identification of Novel Nuclear Factor of Activated T Cell (NFAT)-associated Proteins in T Cells.	ACAD9 RANBP9 RUNX1 ARID1A ADNP RPA1	7.68e-06	178	91	6	27637333
Pubmed	Reduced social interaction and ultrasonic communication in a mouse model of monogenic heritable autism.	NLGN4X NLGN4Y NLGN2	7.71e-06	15	91	3	18227507
Pubmed	SMYD3 Impedes Small Cell Lung Cancer Sensitivity to Alkylation Damage through RNF113A Methylation-Phosphorylation Cross-talk.	TRERF1 NCOA3 DDX18 RBM14 TAF15 FUS USP54 RPA1 CAPRIN1 NDUFS1	8.56e-06	655	91	10	35819319
Pubmed	Resolution of cell fate decisions revealed by single-cell gene expression analysis from zygote to blastocyst.	TRERF1 SOX2 NCOA3 ZBTB20 FOSL2 ZMIZ2 CSRP2 ZBTB5 ARID1A RFX3 STAT5B	8.70e-06	808	91	11	20412781
Pubmed	Histone-binding of DPF2 mediates its repressive role in myeloid differentiation.	ACAD9 RBM14 TAF15 FUS RUNX1 ARID1A RPA1	9.91e-06	283	91	7	28533407
Pubmed	Sox2 cooperates with Chd7 to regulate genes that are mutated in human syndromes.	SOX2 ZBTB20 ARID1A RFX3	1.16e-05	53	91	4	21532573
Pubmed	Disruptions in asymmetric centrosome inheritance and WDR62-Aurora kinase B interactions in primary microcephaly.	SOX2 TLE4 WDR62	1.37e-05	18	91	3	28272472
Pubmed	The hippo pathway effector Yap controls patterning and differentiation of airway epithelial progenitors.	SOX2 TGFBI AXIN2	1.63e-05	19	91	3	25043473
Pubmed	An epigenetic circuit controls neurogenic programs during neocortex development.	SOX2 ZBTB20 ARID1A	1.91e-05	20	91	3	35020876
Pubmed	A dynamic gradient of Wnt signaling controls initiation of neurogenesis in the mammalian cortex and cellular specification in the hippocampus.	SOX2 POU3F2 AXIN2	1.91e-05	20	91	3	17916349
Pubmed	Decoding spatiotemporal transcriptional dynamics and epithelial fibroblast crosstalk during gastroesophageal junction development through single cell analysis.	SOX2 DKK2 AXIN2	1.91e-05	20	91	3	38594232
Pubmed	The Master Neural Transcription Factor BRN2 Is an Androgen Receptor-Suppressed Driver of Neuroendocrine Differentiation in Prostate Cancer.	SOX2 POU3F2	2.03e-05	3	91	2	27784708
Pubmed	Co-activator activator (CoAA) prevents the transcriptional activity of Runt domain transcription factors.	RBM14 RUNX1	2.03e-05	3	91	2	19585539
Pubmed	Selective interactions of hnRNP M isoforms with the TET proteins TAF15 and TLS/FUS.	TAF15 FUS	2.03e-05	3	91	2	24474660
Pubmed	The multifunctional FUS, EWS and TAF15 proto-oncoproteins show cell type-specific expression patterns and involvement in cell spreading and stress response.	TAF15 FUS	2.03e-05	3	91	2	18620564
Pubmed	Disruption of astrocytic glutamine turnover by manganese is mediated by the protein kinase C pathway.	PRKCD SLC38A3	2.03e-05	3	91	2	21812036
Pubmed	KLRD1, FOSL2 and LILRB3 as potential biomarkers for plaques progression in acute myocardial infarction and stable coronary artery disease.	LILRB3 FOSL2	2.03e-05	3	91	2	34271875
Pubmed	mRNA and protein levels of FUS, EWSR1, and TAF15 are upregulated in liposarcoma.	TAF15 FUS	2.03e-05	3	91	2	21344536
Pubmed	Aggregation of FET Proteins as a Pathological Change in Amyotrophic Lateral Sclerosis.	TAF15 FUS	2.03e-05	3	91	2	27311318
Pubmed	Low-Grade Astrocytoma Mutations in IDH1, P53, and ATRX Cooperate to Block Differentiation of Human Neural Stem Cells via Repression of SOX2.	SOX2 IDH1	2.03e-05	3	91	2	29091765
Pubmed	Mutagenesis analysis of human SM22: characterization of actin binding.	PRKCD TAGLN	2.03e-05	3	91	2	11053353
Pubmed	O-GlcNAc glycosylation stoichiometry of the FET protein family: only EWS is glycosylated with a high stoichiometry.	TAF15 FUS	2.03e-05	3	91	2	27903134
Pubmed	The Sox2 regulatory region 2 functions as a neural stem cell-specific enhancer in the telencephalon.	SOX2 POU3F2	2.03e-05	3	91	2	16547000
Pubmed	Proteomic analysis of FUS interacting proteins provides insights into FUS function and its role in ALS.	TAF15 FUS	2.03e-05	3	91	2	27460707
Pubmed	Gene fusion detection in formalin-fixed paraffin-embedded benign fibrous histiocytomas using fluorescence in situ hybridization and RNA sequencing.	PRKCD ALK	2.03e-05	3	91	2	26121314
Pubmed	Gene expression responses to FUS, EWS, and TAF15 reduction and stress granule sequestration analyses identifies FET-protein non-redundant functions.	TAF15 FUS	2.03e-05	3	91	2	23049996
Pubmed	It Takes a Village to Unmask HSTL.	PIK3CD STAT5B	2.03e-05	3	91	2	28373165
Pubmed	circZNF532 promotes endothelial-to-mesenchymal transition in diabetic retinopathy by recruiting TAF15 to stabilize PIK3CD.	PIK3CD TAF15	2.03e-05	3	91	2	38811189
Pubmed	The Genetic Basis of Hepatosplenic T-cell Lymphoma.	PIK3CD INO80	2.03e-05	3	91	2	28122867
Pubmed	RUNX1 regulates phosphoinositide 3-kinase/AKT pathway: role in chemotherapy sensitivity in acute megakaryocytic leukemia.	PIK3CD RUNX1	2.03e-05	3	91	2	19638627
Pubmed	Runt-Related Transcription Factor 1 (RUNX1) Promotes TGF-β-Induced Renal Tubular Epithelial-to-Mesenchymal Transition (EMT) and Renal Fibrosis through the PI3K Subunit p110δ.	PIK3CD RUNX1	2.03e-05	3	91	2	29759484
Pubmed	Evolution of the Autism-Associated Neuroligin-4 Gene Reveals Broad Erosion of Pseudoautosomal Regions in Rodents.	NLGN4X NLGN4Y	2.03e-05	3	91	2	32011705
Pubmed	Association of Wnt signaling pathway genetic variants in gallbladder cancer susceptibility and survival.	DKK2 AXIN2	2.03e-05	3	91	2	26715268
Pubmed	A conserved N-terminal motif is required for complex formation between FUS, EWSR1, TAF15 and their oncogenic fusion proteins.	TAF15 FUS	2.03e-05	3	91	2	23975937
Pubmed	Pivotal role of the RanBP9-cofilin pathway in Aβ-induced apoptosis and neurodegeneration.	ZBTB20 RANBP9	2.03e-05	3	91	2	22361682
Pubmed	FET proteins TAF15 and EWS are selective markers that distinguish FTLD with FUS pathology from amyotrophic lateral sclerosis with FUS mutations.	TAF15 FUS	2.03e-05	3	91	2	21856723
Pubmed	Role of FET proteins in neurodegenerative disorders.	TAF15 FUS	2.03e-05	3	91	2	27415968
Pubmed	SNX10 is required for osteoclast formation and resorption activity.	ACP5 CTSK	2.03e-05	3	91	2	22174188
Pubmed	Analysis of the neuroligin 4Y gene in patients with autism.	NLGN4X NLGN4Y	2.03e-05	3	91	2	18628683
Pubmed	RUNX1 and REXO2 are associated with the heterogeneity and prognosis of IDH wild type lower grade glioma.	IDH1 RUNX1	2.03e-05	3	91	2	34088969
Pubmed	Interactions of myeloma cells with osteoclasts promote tumour expansion and bone degradation through activation of a complex signalling network and upregulation of cathepsin K, matrix metalloproteinases (MMPs) and urokinase plasminogen activator (uPA).	ACP5 CTSK	2.03e-05	3	91	2	18053985
Pubmed	Characterization of a new brain-specific isoform of the EWS oncoprotein.	TAF15 FUS	2.03e-05	3	91	2	11422378
Pubmed	Whole-exome sequencing identifies recessive WDR62 mutations in severe brain malformations.	SOX2 WDR62	2.03e-05	3	91	2	20729831
Pubmed	Cell-cycle-specific nestin expression coordinates with morphological changes in embryonic cortical neural progenitors.	SOX2 POU3F2	2.03e-05	3	91	2	18349072
Pubmed	Reciprocal interaction between SIRT6 and APC/C regulates genomic stability.	MYCBP2 DDX18 FUS USP54 ARID1A ADNP HECTD1 CAPRIN1	2.09e-05	440	91	8	34244565
Pubmed	A global genomic transcriptional code associated with CNS-expressed genes.	EBF2 SOX2 ZBTB20 KLHL1 DDX18 NDUFS1 SEMA4G	2.10e-05	318	91	7	16919269
Pubmed	Genetic and Proteomic Interrogation of Lower Confidence Candidate Genes Reveals Signaling Networks in β-Catenin-Active Cancers.	KIF21A DDX18 RANBP9 TAF15 IDH1 FUS RUNX1 ARID1A RPA1 HECTD1 CAPRIN1 NDUFS1 AXIN2	2.18e-05	1247	91	13	27684187
Pubmed	Chromatin remodeler Arid1a regulates subplate neuron identity and wiring of cortical connectivity.	SOX2 TLE4 ARID1A	2.23e-05	21	91	3	34011608
Pubmed	ZBTB20 is crucial for the specification of a subset of callosal projection neurons and astrocytes in the mammalian neocortex.	ZBTB20 TLE4 ZBTB5 POU3F2	2.32e-05	63	91	4	34351428
Pubmed	Enhancer recruitment of transcription repressors RUNX1 and TLE3 by mis-expressed FOXC1 blocks differentiation in acute myeloid leukemia.	PRKCD RUNX1 ARID1A ADNP RPA1	2.52e-05	131	91	5	34551306
Pubmed	A census of human transcription factors: function, expression and evolution.	TRERF1 SOX2 NCOA3 LHX4 PAX8 FOSL2 POU3F2 RUNX1 ADNP RFX3 STAT5B	2.56e-05	908	91	11	19274049
Pubmed	Cyp26b1 is an essential regulator of distal airway epithelial differentiation during lung development.	SOX2 TGFBI TAGLN AXIN2	2.63e-05	65	91	4	32001436
Pubmed	FET family fusion oncoproteins target the SWI/SNF chromatin remodeling complex.	TAF15 FUS ARID1A	2.95e-05	23	91	3	30962207
Pubmed	Landscape of the SOX2 protein-protein interactome.	SOX2 RBM14 TAF15 FUS CAPRIN1	3.02e-05	136	91	5	21280222
Pubmed	PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.	TRERF1 NCOA3 MYCBP2 FOSL2 ZMIZ2 RBM14 FUS RUNX1 ARID1A ADNP RPA1 CAPRIN1	3.07e-05	1103	91	12	34189442
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	TRERF1 NCOA3 MYCBP2 TLE4 FOSL2 RBM14 PRKCD RUNX1 GPRIN1 WDR62	3.57e-05	774	91	10	15302935
Pubmed	Symmetric neural progenitor divisions require chromatin-mediated homologous recombination DNA repair by Ino80.	SOX2 TLE4 INO80	3.82e-05	25	91	3	32737294
Pubmed	Post-transcriptional regulation of FUS and EWS protein expression by miR-141 during neural differentiation.	TAF15 FUS	4.05e-05	4	91	2	28453628
Pubmed	MLL4 Regulates the Progression of Non-Small-Cell Lung Cancer by Regulating the PI3K/AKT/SOX2 Axis.	SOX2 PIK3CD	4.05e-05	4	91	2	36701842
Pubmed	Potentiated Hsp104 variants suppress toxicity of diverse neurodegenerative disease-linked proteins.	TAF15 FUS	4.05e-05	4	91	2	25062688
Interaction	SMARCC2 interactions	SOX2 NCOA3 MYCBP2 RBM14 TAF15 FUS RUNX1 ARID1A ADNP RPA1 ZRANB1 CAPRIN1	5.57e-08	353	90	12	int:SMARCC2
Interaction	FLI1 interactions	SOX2 PRKCD TAF15 FUS RUNX1 ARID1A	3.37e-07	62	90	6	int:FLI1
Interaction	ARID1A interactions	SOX2 DCAF6 LHX4 PAX8 TAF15 FUS RUNX1 ARID1A ADNP RPA1	4.30e-07	276	90	10	int:ARID1A
Interaction	TLE3 interactions	TRERF1 SOX2 NCOA3 PAX8 TLE4 ZMIZ2 RBM14 TAF15 RUNX1 ARID1A ZRANB1	9.18e-07	376	90	11	int:TLE3
Interaction	NCOR2 interactions	SOX2 NCOA3 LHX4 PAX8 RANBP9 ZBTB5 RUNX1 RPA1 STAT5B	2.78e-06	264	90	9	int:NCOR2
Interaction	EP300 interactions	TRERF1 SOX2 NCOA3 PAX8 ACAD9 FOSL2 DDX18 RBM14 ZBTB5 PRKCD POU3F2 TAF15 HMGCR FUS RUNX1 ARID1A RPA1 HECTD1 ZRANB1 STAT5B	2.82e-06	1401	90	20	int:EP300
Interaction	DPF2 interactions	SOX2 LHX4 PAX8 ACAD9 DDX18 RBM14 RUNX1 ARID1A RPA1 ZRANB1	3.57e-06	349	90	10	int:DPF2
Interaction	MTA2 interactions	SOX2 DCAF6 RBM14 RUNX1 ARID1A RPA1 RFX3 HECTD1 PMEPA1 ZRANB1 CAPRIN1	3.76e-06	435	90	11	int:MTA2
Interaction	ARID2 interactions	SOX2 LHX4 FUS ARID1A RPA1 HECTD1 ZRANB1	5.59e-06	153	90	7	int:ARID2
Interaction	SMARCA4 interactions	SOX2 LHX4 ZMIZ2 TAF15 FUS RUNX1 ARID1A ADNP RPA1 HECTD1 ZRANB1	6.66e-06	462	90	11	int:SMARCA4
Interaction	AR interactions	TRERF1 NCOA3 DCAF6 MYCBP2 TLE4 FOSL2 ZMIZ2 RBM14 RANBP9 TAF15 USP54 RUNX1 ARID1A ADNP RPA1 PMEPA1	7.31e-06	992	90	16	int:AR
Interaction	CSTF2T interactions	CPEB4 RBM14 TAF15 RUNX1 RPA1 ZRANB1	7.57e-06	105	90	6	int:CSTF2T
Interaction	NFATC1 interactions	DCAF6 ACAD9 RANBP9 RUNX1 ARID1A ADNP RPA1	1.03e-05	168	90	7	int:NFATC1
Interaction	SOX2 interactions	TRERF1 SOX2 NCOA3 ZMIZ2 DDX18 RBM14 RANBP9 NAV3 ZBTB5 PRKCD TAF15 IDH1 FUS RUNX1 ARID1A ADNP RPA1 RFX3 CAPRIN1	1.35e-05	1422	90	19	int:SOX2
Interaction	SLC38A3 interactions	PRKCD ZRANB1 SLC38A3	1.38e-05	11	90	3	int:SLC38A3
Interaction	BRD9 interactions	RANBP6 INO80 RUNX1 ARID1A RPA1 ZRANB1	1.41e-05	117	90	6	int:BRD9
Interaction	NKX2-1 interactions	NCOA3 PAX8 RBM14 TAF15 FUS RUNX1 RPA1	1.61e-05	180	90	7	int:NKX2-1
Interaction	IGF2BP1 interactions	SOX2 TLE4 CPEB4 RBM14 HMGCR FUS RUNX1 RPA1 HECTD1 ZRANB1 CAPRIN1	1.62e-05	508	90	11	int:IGF2BP1
Interaction	SNX27 interactions	TGFBI DCAF6 NLGN4X MTM1 RANBP9 ZBTB5 NLGN2 FUS ARID1A RPA1 ZRANB1	1.65e-05	509	90	11	int:SNX27
Interaction	CKAP2 interactions	SOX2 LDHD MYCBP2 RPA1 HECTD1 ZRANB1	2.15e-05	126	90	6	int:CKAP2
Interaction	FAM120A interactions	SOX2 CPEB4 TAF15 FUS RPA1 HECTD1 ZRANB1 CAPRIN1 YARS2	2.60e-05	349	90	9	int:FAM120A
Interaction	SMARCD1 interactions	SOX2 LHX4 PAX8 FUS USP54 RUNX1 ARID1A RPA1 CUEDC1	2.60e-05	349	90	9	int:SMARCD1
Interaction	SAFB2 interactions	RBM14 TAF15 FUS RPA1 HECTD1 ZRANB1 JPH3	2.70e-05	195	90	7	int:SAFB2
Interaction	HNRNPUL1 interactions	LHX4 PAX8 TLE4 RANBP9 TAF15 FUS RPA1 HECTD1 ZRANB1	2.72e-05	351	90	9	int:HNRNPUL1
Interaction	CCNK interactions	SOX2 USP54 RUNX1 RPA1 HECTD1 ZRANB1	2.80e-05	132	90	6	int:CCNK
Interaction	MYCBP2 interactions	DCAF6 MYCBP2 ROBO2 TAF15 FUS RPA1 HECTD1 ZRANB1 CAPRIN1	2.97e-05	355	90	9	int:MYCBP2
Interaction	RALY interactions	SOX2 PIK3CD RBM14 TAF15 FUS RPA1 HECTD1 ZRANB1 WDR62	3.04e-05	356	90	9	int:RALY
Interaction	SMAD3 interactions	NCOA3 PAX8 RBM14 RANBP9 RUNX1 ARID1A RPA1 ZRANB1 AXIN2 JPH3	3.06e-05	447	90	10	int:SMAD3
Interaction	RBM14 interactions	SOX2 DDX18 CPEB4 RBM14 RANBP9 TAF15 FUS RUNX1 RPA1 HECTD1 ZRANB1	3.53e-05	553	90	11	int:RBM14
Interaction	DDX1 interactions	SOX2 CPEB4 RANBP9 TAF15 FUS RUNX1 RPA1 RFX3 HECTD1 ZRANB1	4.12e-05	463	90	10	int:DDX1
Interaction	NFIB interactions	SOX2 NCOA3 LHX4 PAX8 ARID1A RPA1	4.21e-05	142	90	6	int:NFIB
Interaction	NOL9 interactions	SOX2 MYCBP2 RANBP6 RPA1 HECTD1 ZRANB1	4.21e-05	142	90	6	int:NOL9
Interaction	SMARCE1 interactions	SOX2 NCOA3 ZMIZ2 RBM14 RUNX1 ARID1A RPA1 ZRANB1	4.33e-05	287	90	8	int:SMARCE1
Interaction	SS18 interactions	SOX2 RBM14 FUS ARID1A ZRANB1	4.65e-05	88	90	5	int:SS18
Interaction	TAGLN interactions	PIK3CD PRKCD USP54 TAGLN ZRANB1	5.18e-05	90	90	5	int:TAGLN
Interaction	SMARCC1 interactions	SOX2 NCOA3 MYCBP2 TAF15 FUS RUNX1 ARID1A ZRANB1 CAPRIN1	5.47e-05	384	90	9	int:SMARCC1
Interaction	FUBP3 interactions	SOX2 CPEB4 RBM14 FUS USP54 RPA1 ZRANB1 CAPRIN1	5.51e-05	297	90	8	int:FUBP3
Interaction	CHD7 interactions	SOX2 ZBTB20 LHX4 PAX8 ARID1A ZRANB1	5.72e-05	150	90	6	int:CHD7
Interaction	PCID2 interactions	DCAF6 ADPRS RPA1 HECTD1 ZRANB1	5.75e-05	92	90	5	int:PCID2
Interaction	DNTTIP1 interactions	TRERF1 SOX2 LHX4 PAX8 RPA1	6.70e-05	95	90	5	int:DNTTIP1
Interaction	BTG3 interactions	MYCBP2 MTM1 DDX18 RANBP9 KCNQ2	7.78e-05	98	90	5	int:BTG3
Interaction	LARS2 interactions	PIK3CD ACAD9 RPA1 ZRANB1 ALK YARS2	8.48e-05	161	90	6	int:LARS2
Interaction	TAF15 interactions	SOX2 MYCBP2 RBM14 TAF15 FUS RUNX1 ARID1A RPA1 ZRANB1	8.69e-05	408	90	9	int:TAF15
Interaction	FAM98A interactions	SOX2 LDHD CPEB4 FUS RPA1 HECTD1 ZRANB1	9.29e-05	237	90	7	int:FAM98A
Interaction	CSTF2 interactions	RBM14 FUS USP54 RUNX1 RPA1 ZRANB1	9.70e-05	165	90	6	int:CSTF2
Interaction	GLYR1 interactions	SOX2 DDX18 ADNP RPA1 HECTD1 ZRANB1 CAPRIN1	9.79e-05	239	90	7	int:GLYR1
Interaction	ING1 interactions	SOX2 DCAF6 ARID1A ZRANB1 DKK2	9.85e-05	103	90	5	int:ING1
Interaction	EBNA1BP2 interactions	SOX2 DDX18 RANBP9 FUS ADNP RPA1 HECTD1 ZRANB1	1.01e-04	324	90	8	int:EBNA1BP2
Interaction	DHX30 interactions	SOX2 LDHD ACAD9 RBM14 FUS RPA1 HECTD1 ZRANB1 CAPRIN1 NDUFS1	1.03e-04	517	90	10	int:DHX30
Interaction	DMBT1 interactions	EBF2 RANBP9 RUNX1 PMEPA1	1.07e-04	55	90	4	int:DMBT1
Interaction	HDAC1 interactions	TRERF1 SOX2 MYCBP2 TLE4 ZMIZ2 RANBP9 ZBTB5 RUNX1 ARID1A ADNP RPA1 RFX3 HECTD1 ZRANB1 CAPRIN1	1.09e-04	1108	90	15	int:HDAC1
Interaction	LILRA6 interactions	LILRB3 LILRA6	1.18e-04	4	90	2	int:LILRA6
Interaction	EGR2 interactions	TRERF1 NCOA3 ZMIZ2 ACP5 INO80 ARID1A	1.18e-04	171	90	6	int:EGR2
Interaction	HDAC2 interactions	SOX2 MYCBP2 ACAD9 RBM14 RANBP9 TAF15 FUS RUNX1 ARID1A RPA1 RFX3 ZRANB1 CAPRIN1	1.18e-04	865	90	13	int:HDAC2
Interaction	MACF1 interactions	SOX2 MYCBP2 RBM14 PRKCD RPA1 HECTD1 ZRANB1	1.20e-04	247	90	7	int:MACF1
Interaction	DDX52 interactions	SOX2 LHX4 DDX18 RPA1 HECTD1 ZRANB1	1.26e-04	173	90	6	int:DDX52
Interaction	PRPF6 interactions	DDX18 RBM14 RANBP9 TAF15 FUS RPA1 HECTD1 ZRANB1	1.30e-04	336	90	8	int:PRPF6
Interaction	HNRNPR interactions	SOX2 DDX18 RBM14 TAF15 FUS RUNX1 RPA1 HECTD1 ZRANB1 CAPRIN1	1.38e-04	536	90	10	int:HNRNPR
Interaction	PCF11 interactions	RBM14 FUS RPA1 ZRANB1 CAPRIN1	1.40e-04	111	90	5	int:PCF11
Interaction	ARID1B interactions	SOX2 NCOA3 LHX4 PAX8 ARID1A RPA1	1.43e-04	177	90	6	int:ARID1B
Interaction	EMG1 interactions	SOX2 RANBP9 RUNX1 RPA1 ZRANB1	1.52e-04	113	90	5	int:EMG1
Interaction	NEDD4 interactions	TRERF1 RBM14 RUNX1 ARID1A RPA1 UBOX5 PMEPA1 CTSK SLC38A3 CUEDC1	1.56e-04	544	90	10	int:NEDD4
Interaction	PBRM1 interactions	SOX2 LHX4 PAX8 FUS ARID1A HECTD1 ZRANB1	1.57e-04	258	90	7	int:PBRM1
Interaction	PABPC4 interactions	SOX2 CPEB4 TAF15 FUS RUNX1 RPA1 HECTD1 ZRANB1 CAPRIN1	1.59e-04	442	90	9	int:PABPC4
Interaction	AGTPBP1 interactions	RUNX1 RPA1 HECTD1 ZRANB1	1.60e-04	61	90	4	int:AGTPBP1
Interaction	NSUN5 interactions	DCAF6 RPA1 HECTD1 ZRANB1	1.60e-04	61	90	4	int:NSUN5
Interaction	MAT1A interactions	DCAF6 TLE4 ZRANB1	1.63e-04	24	90	3	int:MAT1A
Interaction	LSM14A interactions	SOX2 MYCBP2 CPEB4 TAF15 HECTD1 ZRANB1 CAPRIN1	1.65e-04	260	90	7	int:LSM14A
Interaction	BCL7C interactions	SOX2 LHX4 PAX8 INO80 ARID1A	1.66e-04	115	90	5	int:BCL7C
Interaction	LCP1 interactions	EBF2 SOX2 RUNX1 RPA1 DKK2	1.66e-04	115	90	5	int:LCP1
Interaction	SMARCD2 interactions	SOX2 LHX4 PAX8 ARID1A RPA1 ZRANB1	1.71e-04	183	90	6	int:SMARCD2
Interaction	HS2ST1 interactions	DCAF6 NLGN2 RPA1 HECTD1 ZRANB1	1.80e-04	117	90	5	int:HS2ST1
Interaction	MEN1 interactions	FOSL2 DDX18 RBM14 PRKCD TAF15 FUS INO80 RUNX1 ARID1A ADNP RPA1 CAPRIN1 WDR62 YARS2	1.80e-04	1029	90	14	int:MEN1
Interaction	TKT interactions	SOX2 SELENOO PRKCD IDH1 FUS RUNX1 RPA1 ZRANB1	1.82e-04	353	90	8	int:TKT
Interaction	CPLANE1 interactions	SOX2 RPA1 NDUFS1	1.84e-04	25	90	3	int:CPLANE1
Interaction	EWSR1 interactions	SOX2 NCOA3 SEC24D MYCBP2 CSRP2 RANBP9 TAF15 FUS RUNX1 ARID1A RPA1 RFX3 ZRANB1	1.87e-04	906	90	13	int:EWSR1
Interaction	ITCH interactions	TRERF1 SOX2 RBM14 TAF15 ARID1A RPA1 ZRANB1 CUEDC1	1.93e-04	356	90	8	int:ITCH
Interaction	NFIA interactions	SOX2 NCOA3 LHX4 PAX8 ARID1A ADNP	1.98e-04	188	90	6	int:NFIA
Interaction	TOLLIP interactions	SOX2 SLC38A2 CSRP2 USP54 RUNX1 HECTD1 ZRANB1 NDUFS1	2.00e-04	358	90	8	int:TOLLIP
Interaction	SFPQ interactions	RBM14 TAF15 IDH1 FUS RUNX1 ADNP RPA1 HECTD1 ZRANB1 CAPRIN1	2.06e-04	563	90	10	int:SFPQ
Interaction	HNF1B interactions	SOX2 NCOA3 LHX4 PAX8 USP54 ARID1A	2.10e-04	190	90	6	int:HNF1B
Interaction	NCOA5 interactions	RBM14 FUS HECTD1 ZRANB1 JPH3	2.10e-04	121	90	5	int:NCOA5
Interaction	NCOR1 interactions	SOX2 NCOA3 LHX4 PAX8 ZBTB5 RUNX1 RPA1 ZRANB1	2.20e-04	363	90	8	int:NCOR1
Interaction	DDX5 interactions	SOX2 DDX18 RBM14 RANBP9 TAF15 FUS RUNX1 RPA1 HECTD1 ZRANB1	2.21e-04	568	90	10	int:DDX5
Interaction	PABPN1 interactions	SOX2 MYCBP2 RANBP9 FUS HECTD1 ZRANB1	2.22e-04	192	90	6	int:PABPN1
Interaction	HNRNPDL interactions	ACAD9 RBM14 TAF15 FUS RPA1 HECTD1 ZRANB1 YARS2	2.24e-04	364	90	8	int:HNRNPDL
Interaction	METTL15 interactions	LIPT1 MYCBP2 ACAD9 HECTD1 ZRANB1 NDUFS1 YARS2	2.27e-04	274	90	7	int:METTL15
Interaction	AKAP8 interactions	SOX2 RBM14 FUS RPA1 HECTD1 ZRANB1	2.28e-04	193	90	6	int:AKAP8
Interaction	RBBP4 interactions	SOX2 ZBTB20 FUS RUNX1 ARID1A RPA1 HECTD1 ZRANB1 CAPRIN1 STAT5B	2.37e-04	573	90	10	int:RBBP4
Interaction	GNL3 interactions	SOX2 DDX18 RANBP9 FUS RPA1 HECTD1 ZRANB1 CAPRIN1	2.41e-04	368	90	8	int:GNL3
Interaction	TOP3B interactions	MYCBP2 PIK3CD PLA2G4B FOSL2 ZMIZ2 CPEB4 RBM14 KCNQ2 NLGN2 TAF15 INO80 TAGLN ARID1A RPA1 HECTD1 CAPRIN1 AXIN2	2.43e-04	1470	90	17	int:TOP3B
Interaction	NUMA1 interactions	SOX2 RANBP9 TAF15 FUS ADNP RPA1 HECTD1 ZRANB1 CAPRIN1	2.47e-04	469	90	9	int:NUMA1
Interaction	BPTF interactions	SOX2 KIF21A ARID1A RPA1 HECTD1 ZRANB1	2.55e-04	197	90	6	int:BPTF
Interaction	RNF113A interactions	TRERF1 NCOA3 DDX18 RBM14 TAF15 FUS USP54 RPA1 ZRANB1 CAPRIN1 NDUFS1	2.56e-04	692	90	11	int:RNF113A
Interaction	CKAP2L interactions	SOX2 HECTD1 ZRANB1	2.60e-04	28	90	3	int:CKAP2L
Interaction	PWP1 interactions	SOX2 LHX4 DDX18 RANBP9 HECTD1 ZRANB1	2.62e-04	198	90	6	int:PWP1
Interaction	CHD4 interactions	SOX2 DCAF6 DDX18 RBM14 ZBTB5 TAF15 FUS ARID1A ADNP RPA1 HECTD1 ZRANB1 CAPRIN1	2.62e-04	938	90	13	int:CHD4
Interaction	EFHD2 interactions	SOX2 MYCBP2 IDH1 RPA1 ZRANB1	2.63e-04	127	90	5	int:EFHD2
Interaction	ADNP interactions	SOX2 KIF21A ARID1A ADNP RPA1 ZRANB1	2.69e-04	199	90	6	int:ADNP
Interaction	MRTO4 interactions	SOX2 RANBP9 ARID1A RPA1 HECTD1 ZRANB1	2.76e-04	200	90	6	int:MRTO4
GeneFamily	Zinc fingers RANBP2-type \|RNA binding motif containing	TAF15 FUS ZRANB1	4.00e-05	21	58	3	89
Coexpression	STEARMAN_LUNG_CANCER_EARLY_VS_LATE_DN	LILRB3 ACP5 POU3F2 CTSK AXIN2	2.71e-06	63	91	5	M10880
Coexpression	PHONG_TNF_RESPONSE_VIA_P38_COMPLETE	SEC24D FOSL2 ZMIZ2 NAV3 ZBTB5 HMGCR IDH1	1.33e-05	224	91	7	M2500
Coexpression	GSE37301_HEMATOPOIETIC_STEM_CELL_VS_GRAN_MONO_PROGENITOR_DN	SEC24D FOSL2 CSRP2 HMGCR KDSR AXIN2	3.50e-05	176	91	6	M8884
Coexpression	DURCHDEWALD_SKIN_CARCINOGENESIS_DN	TGFBI FMN1 CPEB4 RANBP9 RUNX1 ADNP PMEPA1	3.92e-05	265	91	7	M1684
Coexpression	DURCHDEWALD_SKIN_CARCINOGENESIS_DN	TGFBI FMN1 CPEB4 RANBP9 RUNX1 ADNP PMEPA1	4.62e-05	272	91	7	MM1027
Coexpression	GABRIELY_MIR21_TARGETS	SOX2 ZBTB20 MYCBP2 ADNP HECTD1 ZRANB1 CAPRIN1	6.76e-05	289	91	7	M2196
Coexpression	GENTILE_UV_HIGH_DOSE_DN	NCOA3 TLE4 FOSL2 NAV3 PRKCD RUNX1 ADNP	6.76e-05	289	91	7	M13630
Coexpression	GSE41867_DAY15_EFFECTOR_VS_DAY30_EXHAUSTED_CD8_TCELL_LCMV_CLONE13_DN	NCOA3 LIPT1 SELENOO HMGCR ADNP NDUFS1	7.12e-05	200	91	6	M9453
ToppCell	E18.5-samps-Mesenchymal-Myofibroblast\|E18.5-samps / Age Group, Lineage, Cell class and subclass	TGFBI ROBO2 NLGN2 TAGLN RPA1 PMEPA1	2.09e-06	183	91	6	de08f9ea02b7244d5a8788064631d10f06565337
ToppCell	3'_v3-lymph-node_spleen-Hematopoietic_progenitors-Cycling_pre-Myeloid-2\|lymph-node_spleen / Manually curated celltypes from each tissue	ACAD9 LILRA6 IDH1 UBOX5 CAPRIN1 WDR62	2.37e-06	187	91	6	3c10b8501226c69d71bcd99dc1c064a3c2154f87
ToppCell	E15.5-Mesenchymal-myocytic_cell\|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	TGFBI CSRP2 ROBO2 FHDC1 TAGLN PMEPA1	2.84e-06	193	91	6	3316d6a39abb6a518d45b846254325fc7a8b2035
ToppCell	E15.5-Mesenchymal-myocytic_cell-aortic_smooth_muscle_cell\|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	TGFBI CSRP2 ROBO2 FHDC1 TAGLN PMEPA1	2.84e-06	193	91	6	e787e618f6e8a1e22be366ce606bf78831b60a90
ToppCell	E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	TGFBI ROBO2 TAGLN RPA1 PMEPA1 AXIN2	3.01e-06	195	91	6	b0d408f8bc1701a87596ed55efcd90749fee33e6
ToppCell	E17.5-Mesenchymal-myocytic_cell-aortic_smooth_muscle_cell\|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	TGFBI CSRP2 ROBO2 TAGLN RPA1 PMEPA1	3.01e-06	195	91	6	1daddd801bd4596fffbdb822fc326d5127c96004
ToppCell	E17.5-Mesenchymal-myocytic_cell\|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	TGFBI CSRP2 ROBO2 TAGLN RPA1 PMEPA1	3.01e-06	195	91	6	01a750d660993017af00736215cbcff2de5909c1
ToppCell	medial-Hematologic-Interstitial_Macrophage-2\|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	TGFBI LILRB3 FMN1 ACP5 LILRA6 SDS	3.19e-06	197	91	6	b90c8a41e99c87b46be699d03cd49c97a2ad51af
ToppCell	medial-Hematologic-Interstitial_Macrophage\|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	TGFBI LILRB3 FMN1 ACP5 LILRA6 SDS	3.19e-06	197	91	6	13aec816e21754eac590a12c3a9c795c41108277
ToppCell	medial-2-Hematologic-Interstitial_Macrophage\|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	TGFBI LILRB3 FMN1 ACP5 LILRA6 SDS	3.19e-06	197	91	6	38a74eeb2a4c8d6a86b133f02f4e6c641f16a3ac
ToppCell	10x_3'_v2v3-Neoplastic-Differentiated-like-AC-like-AC-like-F\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	SOX2 ZBTB20 KIF21A KCNQ2 ROBO2 POU3F2	3.29e-06	198	91	6	81c4c5377d0901ee9594424f08b0e4101686c850
ToppCell	Tracheal-10x3prime_v2-Immune_Myeloid-Macrophage_alveolar-Macro_alv_MT\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	TGFBI PIK3CD ACP5 LILRA6 IDH1 UBOX5	3.39e-06	199	91	6	4e0b73d88b1345ec63a9e5629762341e75beb47f
ToppCell	10x_3'_v2v3-Neoplastic-Differentiated-like\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	SOX2 ZBTB20 KIF21A CSRP2 KCNQ2 POU3F2	3.48e-06	200	91	6	4c20102de2ff7a38e5bff5c65e9fbd0d0310a302
ToppCell	10x_3'_v2v3-Neoplastic\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	SOX2 ZBTB20 KIF21A CSRP2 KCNQ2 POU3F2	3.48e-06	200	91	6	e9c7d7cb5fa63fc92aa91d02ae8bd05438d465bc
ToppCell	367C-Myeloid-Macrophage-SPP1+_Macrophage_4\|367C / Donor, Lineage, Cell class and subclass (all cells)	TGFBI ASPHD1 PAX8 ACP5 LILRA6	1.56e-05	153	91	5	3570dd844d6479425bf6f62129f88efa45553775
ToppCell	facs-Lung-nan-3m-Myeloid-Intermediate_Monocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TGFBI LILRB3 FMN1 ZMIZ2 PRKCD	1.72e-05	156	91	5	3f0b9e35d4da85c90759b930052e5b9c3cde9b15
ToppCell	facs-Lung-nan-3m-Myeloid-intermediate_monocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TGFBI LILRB3 FMN1 ZMIZ2 PRKCD	1.72e-05	156	91	5	69e6e8810d1738a66c9821910f41498931cf30cc
ToppCell	facs-Liver-Liver_non-hepato/SCs-18m-Myeloid-myeloid_leukocyte\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TGFBI LILRB3 LHX4 LILRA6 PRKCD	1.83e-05	158	91	5	bd37d567754b660bfff7aef81cb307a384ec20a0
ToppCell	facs-Aorta-Heart-24m-Myeloid\|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TRERF1 PIK3CD PLA2G4B KLF18 RUNX1	1.88e-05	159	91	5	443f6df4a88fa8755adcde4cc12575dff614ecb4
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	EBF2 TGFBI LHX4 NAV3 TAGLN	1.88e-05	159	91	5	cfb4a8c8aac34b1a857956d98382d487abcf5444
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	EBF2 TGFBI LHX4 NAV3 TAGLN	1.88e-05	159	91	5	a75ab494959575143cefdaec99e7aee3f318d559
ToppCell	droplet-Liver-LIVER_HEP-30m-Myeloid-macrophage/monocyte\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TGFBI LILRB3 MYCBP2 RUNX1 PMEPA1	2.06e-05	162	91	5	93bd29c52846c3156b8b0d2e39c552373efdfe93
ToppCell	facs-Lung-ENDOMUCIN-18m-Myeloid-Classical_Monocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TGFBI LILRB3 LILRA6 PRKCD IDH1	2.32e-05	166	91	5	82fa07632f7e586698fbf37381715b40f9f6ae3a
ToppCell	facs-Lung-EPCAM-18m-Myeloid-Classical_Monocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TGFBI LILRB3 PIK3CD LILRA6 IDH1	2.32e-05	166	91	5	bf6c35c3e67ef4ca98a38926c6f7923ecca0508a
ToppCell	facs-Lung-EPCAM-18m-Myeloid-classical_monocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TGFBI LILRB3 PIK3CD LILRA6 IDH1	2.32e-05	166	91	5	433128b7d964b32faa0bf437a02facc819ab1405
ToppCell	facs-Lung-ENDOMUCIN-18m-Myeloid-classical_monocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TGFBI LILRB3 LILRA6 PRKCD IDH1	2.32e-05	166	91	5	0d03926452414f232c77fd15d5f48d148f9fca3b
ToppCell	3'-GW_trimst-1.5-LargeIntestine-Neuronal-Glial_immature-Differentiating_glia\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SOX2 NLGN4X KIF21A KCNQ2 PMEPA1	2.38e-05	167	91	5	17c653b46507c8bb85da95836ae72a6015336142
ToppCell	3'-GW_trimst-1.5-SmallIntestine-Neuronal-Glial_immature-Glia_2_(ELN+)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SOX2 NLGN4X POU3F2 FHDC1 PMEPA1	2.45e-05	168	91	5	af82e07d1eec51fc6530155f37addbce6221885d
ToppCell	saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A\|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)	SOX2 GALK2 NLGN4Y KIF21A CTSK	2.45e-05	168	91	5	9a8709d34865cfa668d8f3335dc34fc86fc32482
ToppCell	390C-Myeloid-Macrophage-SPP1+_Macrophage_4\|390C / Donor, Lineage, Cell class and subclass (all cells)	TGFBI LILRB3 LILRA6 GPRIN1 SDS	2.60e-05	170	91	5	439167e44a1bd5ac8e1e457351dd202ec968db46
ToppCell	droplet-Lung-LUNG-1m-Myeloid-Classical_Monocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TGFBI LILRB3 LILRA6 PRKCD IDH1	2.75e-05	172	91	5	b26fc612f232e8e273825ac2d2e5519cbb7322cf
ToppCell	droplet-Lung-21m-Hematologic-myeloid-classical_monocyte\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	TGFBI LILRB3 LILRA6 PRKCD IDH1	2.75e-05	172	91	5	a53c906539557594ef10368bc29aec4af063fd37
ToppCell	droplet-Lung-LUNG-1m-Myeloid-classical_monocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TGFBI LILRB3 LILRA6 PRKCD IDH1	2.75e-05	172	91	5	07bf95ffe77347b4f3159cb88adeaddc1b4796b7
ToppCell	droplet-Lung-nan-21m-Myeloid-classical_monocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TGFBI LILRB3 LILRA6 PRKCD IDH1	2.82e-05	173	91	5	9019049b1e2a24cb0bbbc620d64ef29dd18cc4c6
ToppCell	droplet-Lung-nan-21m-Myeloid-Classical_Monocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TGFBI LILRB3 LILRA6 PRKCD IDH1	2.82e-05	173	91	5	077029eecfe636a5baf5f70464e1713b3f6b4274
ToppCell	droplet-Lung-21m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l2\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	TGFBI LILRB3 LILRA6 PRKCD IDH1	2.82e-05	173	91	5	9acad7ec70f713fe3db6cef7bbe3b183bf16ae67
ToppCell	Control-Myeloid-MoAM2,_CCL18\|Control / Condition, Lineage and Cell class	TGFBI FMN1 CTSK ALK SDS	2.90e-05	174	91	5	4c64ff5666812fb4efa440ba4faeca51d916d68e
ToppCell	E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_G2M\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	TGFBI ROBO2 FHDC1 TAGLN WDR62	2.90e-05	174	91	5	7fb7bdf62563f2102fb38618b503eb2817b6594f
ToppCell	facs-Brain_Myeloid-Cerebellum-3m-Myeloid-microglial_cell\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC38A2 DCAF6 NAV3 FUS RUNX1	2.98e-05	175	91	5	1ea6cf9da26601646f57fa14d558a5e9e1f0b345
ToppCell	PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_prolif\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	TGFBI KLHL1 PIK3CD POU3F2 CTSK	3.07e-05	176	91	5	270d7908dbd84028958d257f94941dc685e20255
ToppCell	wk_15-18-Epithelial-PNS-Schwann_precursor\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	NLGN4X PLA2G4B POU3F2 PMEPA1 ALK	3.15e-05	177	91	5	5357359e6c2161a37f39a6b3b78449f5cbc327d1
ToppCell	Control-Myeloid-MoAM2,_CCL18\|Myeloid / Condition, Lineage and Cell class	TGFBI FMN1 CTSK ALK SDS	3.15e-05	177	91	5	470f54fe2b21c7350ea471e02039461a3808f700
ToppCell	metastatic_Brain-B_lymphocytes-GrB-secreting_B_cells\|B_lymphocytes / Location, Cell class and cell subclass	TGFBI SLC12A9 FMN1 FOSL2 LILRA6	3.15e-05	177	91	5	43e1d0d3cf8f0c02e67d91f8dd1761df23d59e07
ToppCell	Somatosensory_Cortex_(S1)\|World / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	FMN1 NLGN4Y EXTL2 RFX3 PMEPA1	3.32e-05	179	91	5	82348bf56a4525b2f485696cab5b2ea6e96c2f91
ToppCell	facs-Bladder-nan-24m-Epithelial-bladder_mesenchymal_cell_(Car3+)\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TGFBI CSRP2 NAV3 CTSK DKK2	3.41e-05	180	91	5	12537d8a569faa69f474284d2c201475722b8ca1
ToppCell	facs-Brain_Non-Myeloid-Cortex-3m-Neuronal-medium_spiny_neuron\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TRERF1 GABRD KLHL1 KCNQ2 ROBO2	3.60e-05	182	91	5	d41ff834b8fc1d0e23cac7ae261de5f72874e462
ToppCell	facs-Brain_Non-Myeloid-Cortex-3m-Neuronal-SPN_Neuron_STR\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TRERF1 GABRD KLHL1 KCNQ2 ROBO2	3.60e-05	182	91	5	6cde859edfe7607bd7ada89d20258413d06f4207
ToppCell	LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	TRERF1 TGFBI ROBO2 NLGN2 TAGLN	3.69e-05	183	91	5	12daaea821e49bc94a01e2496331e92a80d27339
ToppCell	droplet-Lung-21m-Hematologic-myeloid-alveolar_macrophage-alveolar_macrophage\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	TGFBI FOSL2 IDH1 RUNX1 CTSK	3.79e-05	184	91	5	15ea746c77785120f69f9ab370fb7eb9b70692f8
ToppCell	droplet-Lung-21m-Hematologic-myeloid-alveolar_macrophage\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	TGFBI FOSL2 IDH1 RUNX1 CTSK	3.79e-05	184	91	5	bd5e8fc453a6393b8778734a2c3c2f1281769bcd
ToppCell	CV-Moderate-7\|Moderate / Virus stimulation, Condition and Cluster	SLC38A2 MYCBP2 MTM1 HMGCR FUS	3.89e-05	185	91	5	a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f
ToppCell	5'-Adult-LargeIntestine-Neuronal-Glial_mature\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SOX2 NLGN4X OTOGL PMEPA1 ALK	3.89e-05	185	91	5	f607b6ee579562e2f92103fa5c7053df0170a229
ToppCell	5'-Adult-LargeIntestine-Neuronal\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SOX2 NLGN4X OTOGL PMEPA1 ALK	3.89e-05	185	91	5	317f2c854f00aa5957319b818c85eeed7d72ec7f
ToppCell	5'-Adult-LargeIntestine-Neuronal-Glial_mature-Adult_Glia\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SOX2 NLGN4X OTOGL PMEPA1 ALK	3.89e-05	185	91	5	7bb8fdfe04f85d25056380ec58222366de323a21
ToppCell	10x_3'_v2v3-Neoplastic-Differentiated-like-AC-like-AC-like-A\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	SOX2 ZBTB20 KIF21A CSRP2 KCNQ2	4.09e-05	187	91	5	db771e952f71a12886c2dbc77c6cd07054ef809a
ToppCell	Mesenchymal-airway_smooth_muscle_cell\|World / Lineage, Cell type, age group and donor	TGFBI CSRP2 ROBO2 TAGLN PMEPA1	4.41e-05	190	91	5	645e56b02edc3702c7db917b8ecd5eed0decaf71
ToppCell	droplet-Marrow-nan-21m-Myeloid-promonocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TGFBI CSRP2 LILRA6 PRKCD IDH1	4.41e-05	190	91	5	6c6d3259e23ec90c08756f500ae8a7aff8b8a5b3
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-6_SST_MTHFD2P6\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	PIK3CD ROBO2 ALK DKK2 STAT5B	4.53e-05	191	91	5	9c0ee270209b02043393416ecc9a81ddedfbb8b6
ToppCell	5'-GW_trimst-1-SmallIntestine-Neuronal-Glial_immature-cycling_ENCC/glia\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SOX2 NLGN4X KIF21A KCNQ2 ALK	4.76e-05	193	91	5	4f4f430d7e1b65e19ca829f55ca93edeb6c1c85d
ToppCell	TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6\|TCGA-Prostate / Sample_Type by Project: Shred V9	KIF21A ARID1A HECTD1 CAPRIN1 NDUFS1	4.76e-05	193	91	5	abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659
ToppCell	5'-GW_trimst-2-SmallIntestine-Neuronal-Glial_immature-Differentiating_glia\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SOX2 NLGN4X KIF21A KCNQ2 PMEPA1	4.76e-05	193	91	5	d5930f7bd9b299f792212d40a3272a37adf64a82
ToppCell	COVID-19-Heart-Macrophage\|Heart / Disease (COVID-19 only), tissue and cell type	TGFBI LILRB3 FMN1 LILRA6 RUNX1	4.87e-05	194	91	5	f09675cd472200363c458952f00d2e41990800ee
ToppCell	3'-Pediatric_IBD-SmallIntestine-Neuronal-Glial_mature-Adult_Glia\|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SOX2 NLGN4X OTOGL PMEPA1 ALK	4.87e-05	194	91	5	d429bb5e422a07bd92f0dc48cd51528e8b7d9a72
ToppCell	3'-Pediatric_IBD-SmallIntestine-Neuronal\|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SOX2 NLGN4X OTOGL PMEPA1 ALK	4.87e-05	194	91	5	bffdf6db0bf3fb338e7bb0789ae7dcde1fce0094
ToppCell	3'-Pediatric_IBD-SmallIntestine-Neuronal-Glial_mature\|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SOX2 NLGN4X OTOGL PMEPA1 ALK	4.87e-05	194	91	5	408dfc7060095972a54ae37ae8105521df6fbbee
ToppCell	facs-Bladder-nan-3m-Epithelial-bladder_mesenchymal_cell_(Car3+)\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TGFBI SEC24D TAGLN CTSK DKK2	4.99e-05	195	91	5	18b01ab63ee1deae3cf29669d66fff9ca4efc5c4
ToppCell	IPF-Myeloid-Macrophage\|World / Disease state, Lineage and Cell class	TGFBI FMN1 ACP5 CTSK SDS	4.99e-05	195	91	5	50edda117b438b9c3616191884007466f6d974f0
ToppCell	E12.5-Mesenchymal-myocytic_cell-aortic_smooth_muscle_cell\|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	TGFBI ZBTB20 CSRP2 FHDC1 TAGLN	4.99e-05	195	91	5	bff7685784688425bebd78b0f284a6d4475a9415
ToppCell	E12.5-Mesenchymal-myocytic_cell\|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	TGFBI ZBTB20 CSRP2 FHDC1 TAGLN	4.99e-05	195	91	5	aed243418cdb5df4563a7b935c1ecbd744590901
ToppCell	E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_mature\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	TGFBI ROBO2 TAGLN RPA1 AXIN2	4.99e-05	195	91	5	a486a7acea0e91048cc48afa0dbd3926d30bc217
ToppCell	E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	TGFBI ROBO2 TAGLN RPA1 PMEPA1	4.99e-05	195	91	5	2414b158dc7bdec43a9671544bfb7ffc5f5168fd
ToppCell	10x5'v1-week_14-16-Myeloid_macrophage\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	TGFBI ACP5 IDH1 CTSK SDS	5.12e-05	196	91	5	e0447ad2efb021b63c7fef000d39b6b21fbe6113
ToppCell	facs-Trachea\|facs / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	EBF2 SLC38A2 FOSL2 RUNX1 CTSK	5.12e-05	196	91	5	8209f2b0f7efebaaf81d642d18a1aee8a9a8dcf6
ToppCell	distal-Hematologic-Interstitial_Macrophage-3\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	TGFBI LILRB3 ACP5 CTSK SDS	5.12e-05	196	91	5	e4f40274df940e0996c555082f2bb4f99e5b0881
ToppCell	PND01-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	TGFBI CSRP2 ROBO2 TAGLN PMEPA1	5.12e-05	196	91	5	9d7b631f24a19a7dc7a28f28525d4019fc8fcf8a
ToppCell	facs-Trachea\|facs / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EBF2 SLC38A2 FOSL2 RUNX1 CTSK	5.12e-05	196	91	5	34020d6553309daa269dff05de0a8567211ea4d2
ToppCell	10x5'v1-week_14-16-Myeloid_macrophage-stroma\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	TGFBI ACP5 IDH1 CTSK SDS	5.12e-05	196	91	5	3bca88eede3dd7368715ced02e3bacd1e3e82cab
ToppCell	Macrophages-IPF_02\|World / lung cells shred on cell class, cell subclass, sample id	TGFBI LILRB3 ACP5 CTSK SDS	5.12e-05	196	91	5	861c402ed8b8fde3582cc777c1357b45f5a2489b
ToppCell	COVID-19-lung-Macrophage_metabolically_active\|COVID-19 / Disease (COVID-19 only), tissue and cell type	TGFBI LILRB3 FMN1 ACP5 IDH1	5.12e-05	196	91	5	1b7928f4eee94d4bb6ea410bab68a471dba12979
ToppCell	COVID-19-lung-Macrophage_CD163hi_MERTKhi\|COVID-19 / Disease (COVID-19 only), tissue and cell type	TGFBI LILRB3 FMN1 LILRA6 RUNX1	5.12e-05	196	91	5	7026c1fc33425e5476063d17c79e4b79356a9e01
ToppCell	P07-Mesenchymal-myocytic_cell\|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	TGFBI ROBO2 TAGLN RUNX1 PMEPA1	5.24e-05	197	91	5	378299fe2ec6ed2fc858febb78ff1ac0898e457d
ToppCell	PND01-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	TGFBI CSRP2 ROBO2 TAGLN PMEPA1	5.24e-05	197	91	5	7d97c2d51a543c02d679e9257b22d0581e73a11d
ToppCell	droplet-Bladder-BLADDER-1m-Epithelial-bladder_mesenchymal_cell_(Car3+)\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TGFBI TAGLN RPA1 CTSK DKK2	5.24e-05	197	91	5	86145bc1e585b4ae136e755cafd6579da2abfa65
ToppCell	PND01-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_mature\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	TGFBI CSRP2 ROBO2 TAGLN PMEPA1	5.24e-05	197	91	5	671d6b5effbac2dd71d18f48d23c523738db1828
ToppCell	P07-Mesenchymal-myocytic_cell-aortic_smooth_muscle_cell\|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	TGFBI ROBO2 TAGLN RUNX1 PMEPA1	5.24e-05	197	91	5	b1135378d768fbbe62a75747d1e8653d35252187
ToppCell	NS-critical-LOC-Myeloid-Macrophage\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	TGFBI FMN1 ACP5 IDH1 SDS	5.24e-05	197	91	5	5fb0696376a5501b7c87e0f2f5e4fff3da2903f2
ToppCell	Mesenchymal_cells-Arteriolar_fibro.\|Mesenchymal_cells / Lineage and Cell class	TGFBI ACP5 CSRP2 CTSK DKK2	5.24e-05	197	91	5	cb321836980e7b4efbb9284c6af7ccd34079d2be
ToppCell	367C-Fibroblasts-Fibroblast-B_(Myofibroblast)-\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	TGFBI ROBO2 RUNX1 PMEPA1 CTSK	5.37e-05	198	91	5	c55608633f66e3d434c5d81324efb07c5120d2c2
ToppCell	COVID-19-lung-Macrophage_VCANhi_FCN1hi\|COVID-19 / Disease (COVID-19 only), tissue and cell type	LILRB3 FMN1 PIK3CD LILRA6 RUNX1	5.37e-05	198	91	5	ea34096bee852a7e996f097fa279381afa8f86ff
ToppCell	E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	TGFBI CSRP2 ROBO2 TAGLN PMEPA1	5.37e-05	198	91	5	63f7d25201613bd3404c28fb936954190bca91d3
ToppCell	E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	TGFBI CSRP2 ROBO2 TAGLN PMEPA1	5.37e-05	198	91	5	a73534b6ca202c277a70a52281d5b97a3e6cb8ef
ToppCell	10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_anti-infl-G\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	TGFBI LILRB3 FOSL2 ACP5 SDS	5.37e-05	198	91	5	eb0a94c426a7c567f94490b848e28784587c6dcd
ToppCell	E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_mature\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	TGFBI CSRP2 ROBO2 TAGLN PMEPA1	5.37e-05	198	91	5	d1e1bdd36c84e1bac21ba137f018defe98456a8c
ToppCell	distal-Hematologic-Interstitial_Macrophage\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	TGFBI LILRB3 ACP5 CTSK SDS	5.37e-05	198	91	5	a35b43d38e18c6f8f0cd9015b8e23f71c729f023
ToppCell	367C-Fibroblasts-Fibroblast-B_(Myofibroblast)\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	TGFBI ROBO2 RUNX1 PMEPA1 CTSK	5.37e-05	198	91	5	3e5459038fc6ed95f529eb4d1dc5113e16c19012
ToppCell	normal_Lymph_Node-Myeloid_cells\|normal_Lymph_Node / Location, Cell class and cell subclass	TGFBI LILRB3 ACP5 CTSK SDS	5.37e-05	198	91	5	6b956073898192b1c6c8da66416b6a9b20d28a82
ToppCell	Tracheal-10x3prime_v2-Stromal-Fibroblastic-Fibro_myofibroblast\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	SLC38A2 CSRP2 ROBO2 TAGLN AXIN2	5.37e-05	198	91	5	08d393853e195a7eacace454153e425a273e2d23
ToppCell	distal-3-Hematologic-Interstitial_Macrophage\|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	TGFBI LILRB3 ACP5 CTSK SDS	5.37e-05	198	91	5	137a786da9f54b4f17e385a675d50a37de88f1b5
ToppCell	tumor_Lung-Myeloid_cells-mo-Mac\|tumor_Lung / Location, Cell class and cell subclass	TGFBI LILRB3 ACP5 IDH1 SDS	5.50e-05	199	91	5	77d46acf655029eab23471dc4c4a1b0832b24306
ToppCell	10x_3'_v2v3-Non-neoplastic-Myeloid-Mono\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	TGFBI LILRB3 FOSL2 ACP5 LILRA6	5.50e-05	199	91	5	87956fcb39c2e3e99622ff05f99267d7621a78fc
Drug	monomethyl phthalate	TRERF1 TGFBI NCOA3 HMGCR INO80 TAGLN RUNX1 ARID1A ADNP RPA1 PMEPA1 CTSK PGGT1B ALK DKK2 WDR62 STAT5B	2.12e-07	957	91	17	ctd:C517284
Drug	S-methylcysteine	TRERF1 HMGCR SLC38A3 SDS	1.01e-05	34	91	4	CID000024417
Drug	ICI 182,780; Down 200; 0.01uM; MCF7; HT_HG-U133A	GALK2 FOSL2 EXTL2 RUNX1 KDSR WDR62 CUEDC1	1.09e-05	189	91	7	6997_DN
Drug	Idazoxan hydrochloride [79944-56-2]; Up 200; 16.6uM; PC3; HT_HG-U133A	NLGN4X PAX8 PIK3CD ZMIZ2 RUNX1 ALK STAT5B	1.43e-05	197	91	7	6747_UP
Drug	Lumicolchicine gamma [6901-14-0]; Up 200; 10uM; PC3; HT_HG-U133A	ZBTB20 KLHL1 SLC12A9 ZMIZ2 RUNX1 BBS9 WDR62	1.48e-05	198	91	7	4195_UP
Drug	Baclofen (R,S) [1134-47-0]; Down 200; 18.8uM; MCF7; HT_HG-U133A	SEC24D ZMIZ2 TAF15 UBOX5 BBS9 WDR62 CUEDC1	1.53e-05	199	91	7	1536_DN
Drug	Propafenone hydrochloride [34183-22-7]; Up 200; 10.6uM; PC3; HT_HG-U133A	TGFBI GALK2 ASPHD1 FOSL2 POU3F2 RUNX1 BBS9	1.53e-05	199	91	7	6336_UP
Drug	Chlorpheniramine maleate [113-92-8]; Up 200; 10.2uM; MCF7; HT_HG-U133A	PIK3CD TLE4 ARID1A UBOX5 BBS9 SEMA4G WDR62	1.53e-05	199	91	7	6773_UP
Drug	Fenbendazole [43210-67-9]; Down 200; 13.4uM; PC3; HT_HG-U133A	TGFBI ASPHD1 FOSL2 MTM1 RUNX1 BBS9 PGGT1B	1.58e-05	200	91	7	4542_DN
Drug	alpha-bromo-4-chlorophenylacetic acid	LILRB3 LILRA6	4.73e-05	3	91	2	CID010490868
Drug	l-945	LILRB3 LILRA6	4.73e-05	3	91	2	CID000097919
Drug	Magnetite Nanoparticles	TGFBI SLC38A2 ZBTB20 FMN1 FOSL2 ACP5 CSRP2 TAF15 FUS HECTD1 BBS9 PMEPA1 CTSK ZRANB1 PGGT1B SEMA4G	5.73e-05	1310	91	16	ctd:D058185
Drug	fullerene C60	TGFBI NCOA3 LILRB3 AIFM2 DCAF6 ZBTB20 PIK3CD FOSL2 ZMIZ2 MTM1 SELENOO RBM14 GPRIN1 RFX3 CTSK AXIN2 CUEDC1	8.10e-05	1498	91	17	ctd:C069837
Drug	tyrphostin AG-825; Down 200; 25.2uM; MCF7; HT_HG-U133A_EA	SLC38A2 NCOA3 ZBTB5 HMGCR ARID1A ADNP	9.98e-05	185	91	6	1114_DN
Drug	retinoic acid; Up 200; 1uM; MCF7; HT_HG-U133A	TGFBI TLE4 ZMIZ2 PRKCD IDH1 STAT5B	9.98e-05	185	91	6	6931_UP
Drug	Halcinonide [3093-35-4]; Down 200; 8.8uM; PC3; HT_HG-U133A	TLE4 MTM1 TAGLN RUNX1 BBS9 PGGT1B	1.19e-04	191	91	6	7379_DN
Drug	Proglumide [6620-60-6]; Up 200; 12uM; MCF7; HT_HG-U133A	TLE4 FUS RUNX1 UBOX5 ALK SEMA4G	1.19e-04	191	91	6	3861_UP
Drug	dimethyl phthalate	TGFBI NCOA3 HMGCR INO80 TAGLN RUNX1 RPA1 CTSK PGGT1B ALK STAT5B	1.29e-04	714	91	11	ctd:C024629
Drug	Resveratrol [501-36-0]; Up 200; 17.6uM; MCF7; HT_HG-U133A	ZBTB20 ASPHD1 PAX8 FOSL2 ZMIZ2 ALK	1.33e-04	195	91	6	2865_UP
Drug	Procyclidine hydrochloride [1508-76-5]; Up 200; 12.4uM; MCF7; HT_HG-U133A	PIK3CD FOSL2 ZMIZ2 ADAM11 RUNX1 UBOX5	1.33e-04	195	91	6	4817_UP
Drug	Diphenidol hydrochloride [3254-89-5]; Up 200; 11.6uM; MCF7; HT_HG-U133A	SOX2 ASPHD1 TAGLN ARID1A BBS9 ALK	1.33e-04	195	91	6	7406_UP
Drug	Methoxy-8-psoralen [298-81-7]; Down 200; 18.6uM; PC3; HT_HG-U133A	ZBTB20 NAV3 TAGLN ARID1A UBOX5 ALK	1.33e-04	195	91	6	6661_DN
Drug	Eserine sulfate, physostigmine sulfate [64-47-1]; Down 200; 6.2uM; PC3; HT_HG-U133A	GALK2 NAV3 POU3F2 RUNX1 BBS9 ALK	1.37e-04	196	91	6	5749_DN
Drug	Praziquantel [55268-74-1]; Down 200; 12.8uM; MCF7; HT_HG-U133A	GALK2 ASPHD1 SLC12A9 TLE4 FOSL2 BBS9	1.37e-04	196	91	6	7228_DN
Drug	Ethynodiol diacetate [297-76-7]; Down 200; 10.4uM; PC3; HT_HG-U133A	TGFBI MTM1 NAV3 TAGLN ARID1A UBOX5	1.37e-04	196	91	6	6678_DN
Drug	Decamethonium bromide [541-22-0]; Down 200; 9.6uM; MCF7; HT_HG-U133A	SOX2 SEC24D KRT24 SLC12A9 PAX8 WDR62	1.37e-04	196	91	6	7353_DN
Drug	Sulfamethazine sodium salt [1981-58-4]; Up 200; 13.4uM; MCF7; HT_HG-U133A	TLE4 FUS UBOX5 SDS SEMA4G JPH3	1.37e-04	196	91	6	3847_UP
Drug	Diphenidol hydrochloride [3254-89-5]; Down 200; 11.6uM; HL60; HT_HG-U133A	NCOA3 FUS CTSK ALK DKK2 STAT5B	1.37e-04	196	91	6	2374_DN
Drug	Isopropamide iodide [71-81-8]; Up 200; 8.4uM; MCF7; HT_HG-U133A	ASPHD1 PIK3CD ZMIZ2 UBOX5 SEMA4G WDR62	1.37e-04	196	91	6	3461_UP
Drug	genistein; Up 200; 10uM; HL60; HT_HG-U133A	SEC24D KLHL1 PAX8 FOSL2 RUNX1 JPH3	1.37e-04	196	91	6	6194_UP
Drug	Succimer	SLC38A2 ZBTB20 FMN1 FOSL2 ACP5 CSRP2 TAF15 FUS HECTD1 BBS9 PMEPA1 CTSK ZRANB1 PGGT1B SEMA4G	1.38e-04	1264	91	15	ctd:D004113
Drug	Pirenperone [ 75444-65-4]; Up 200; 10.2uM; HL60; HT_HG-U133A	KRT24 FOSL2 RUNX1 UBOX5 BBS9 STAT5B	1.41e-04	197	91	6	2455_UP
Drug	Cefazolin sodium salt [27164-46-1]; Up 200; 8.4uM; HL60; HT_HG-U133A	ZBTB20 ZMIZ2 RUNX1 UBOX5 WDR62 JPH3	1.41e-04	197	91	6	2564_UP
Drug	Quinidine hydrochloride monohydrate [6151-40-2]; Up 200; 10.6uM; MCF7; HT_HG-U133A	PIK3CD TLE4 ZMIZ2 RUNX1 RFX3 UBOX5	1.41e-04	197	91	6	3191_UP
Drug	Vinpocetine [42971-09-5]; Up 200; 11.4uM; PC3; HT_HG-U133A	ASPHD1 ZMIZ2 TAGLN RUNX1 UBOX5 WDR62	1.41e-04	197	91	6	5859_UP
Drug	Cefotiam hydrochloride; Up 200; 7.2uM; MCF7; HT_HG-U133A	SOX2 KRT24 PAX8 FOSL2 ZMIZ2 BBS9	1.41e-04	197	91	6	3319_UP
Drug	Succinylsulfathiazole [116-43-8]; Down 200; 11.2uM; PC3; HT_HG-U133A	ZMIZ2 MTM1 TAF15 UBOX5 BBS9 SEMA4G	1.41e-04	197	91	6	4265_DN
Drug	Tiabendazole [148-79-8]; Down 200; 19.8uM; HL60; HT_HG-U133A	NCOA3 ZBTB20 SLC12A9 PAX8 RUNX1 STAT5B	1.41e-04	197	91	6	2479_DN
Drug	Imidurea [39236-46-9]; Up 200; 10.4uM; PC3; HT_HG-U133A	ZBTB20 ASPHD1 PIK3CD ZMIZ2 RUNX1 SDS	1.45e-04	198	91	6	5062_UP
Drug	Hecogenin [467-55-0]; Up 200; 9.2uM; PC3; HT_HG-U133A	TGFBI GALK2 TLE4 FOSL2 MTM1 SEMA4G	1.45e-04	198	91	6	5818_UP
Drug	Rifampicin [13292-46-1]; Up 200; 4.8uM; MCF7; HT_HG-U133A	SOX2 RUNX1 ARID1A UBOX5 ALK SDS	1.45e-04	198	91	6	4126_UP
Drug	Sulfadoxine [2447-57-6]; Down 200; 12.8uM; PC3; HT_HG-U133A	TAF15 FUS RUNX1 UBOX5 BBS9 PGGT1B	1.45e-04	198	91	6	5852_DN
Drug	Mesoridazine besylate [32672-69-8]; Up 200; 7.4uM; MCF7; HT_HG-U133A	ZBTB20 ZMIZ2 RUNX1 ARID1A ALK SDS	1.45e-04	198	91	6	2874_UP
Drug	Naftopidil dihydrochloride [57149-08-3]; Up 200; 8.6uM; PC3; HT_HG-U133A	KRT24 ZBTB20 PAX8 TLE4 ZMIZ2 BBS9	1.49e-04	199	91	6	4193_UP
Drug	Oleandomycin phosphate [7060-74-4]; Down 200; 5uM; PC3; HT_HG-U133A	TGFBI ZMIZ2 MTM1 TAF15 FUS RUNX1	1.49e-04	199	91	6	4615_DN
Drug	Diphenylpyraline hydrochloride [132-18-3]; Up 200; 12.6uM; MCF7; HT_HG-U133A	EBF2 GABRD PIK3CD ZMIZ2 SEMA4G WDR62	1.49e-04	199	91	6	3640_UP
Drug	oxidized cholesterol	PRKCD HMGCR JPH3	1.50e-04	26	91	3	CID000011754
Drug	Saquinavir mesylate [149845-06-7]; Up 200; 5.2uM; MCF7; HT_HG-U133A	ZMIZ2 ADAM11 RUNX1 UBOX5 ALK WDR62	1.53e-04	200	91	6	6246_UP
Drug	gluconapin	TRERF1 POU3F2	1.57e-04	5	91	2	CID000656550
Drug	NSC606985	PRKCD RUNX1	1.57e-04	5	91	2	CID000354677
Drug	cupric acetate monohydrate	LILRB3 LILRA6	1.57e-04	5	91	2	CID000165397
Drug	Zinc Sulfate	SEC24D ZBTB20 SLC12A9 ACP5 ROBO2 HMGCR IDH1 TAGLN BBS9 CTSK JPH3	1.75e-04	739	91	11	ctd:D019287
Disease	amyotrophic lateral sclerosis type 6 (implicated_via_orthology)	TAF15 FUS	2.69e-05	3	89	2	DOID:0060198 (implicated_via_orthology)
Disease	Intrahepatic Cholangiocarcinoma	ROBO2 IDH1 ARID1A	5.13e-05	24	89	3	C0345905
Disease	Extrahepatic Cholangiocarcinoma	ROBO2 IDH1 ARID1A	5.13e-05	24	89	3	C3805278
Disease	Cholangiocarcinoma	ROBO2 IDH1 ARID1A	6.56e-05	26	89	3	C0206698
Disease	gastric adenocarcinoma (is_marker_for)	ARID1A PMEPA1 STAT5B	8.23e-05	28	89	3	DOID:3717 (is_marker_for)
Disease	Prostatic Neoplasms	SOX2 NCOA3 DCAF6 ZBTB20 PIK3CD ROBO2 IDH1 RUNX1 ARID1A	1.02e-04	616	89	9	C0033578
Disease	Malignant neoplasm of prostate	SOX2 NCOA3 DCAF6 ZBTB20 PIK3CD ROBO2 IDH1 RUNX1 ARID1A	1.02e-04	616	89	9	C0376358
Disease	Giant Cell Glioblastoma	FOSL2 IDH1 RUNX1 CTSK	1.24e-04	84	89	4	C0334588
Disease	leukocyte immunoglobulin-like receptor subfamily B member 3 measurement	LILRB3 LILRA6	1.34e-04	6	89	2	EFO_0802705
Disease	portal hypertension (is_marker_for)	CPEB4 PRKCD	1.34e-04	6	89	2	DOID:10762 (is_marker_for)
Disease	leukocyte immunoglobulin-like receptor subfamily A member 6 measurement	LILRB3 LILRA6	1.34e-04	6	89	2	EFO_0801767
Disease	cancer (implicated_via_orthology)	PIK3CD RANBP6 IDH1 ARID1A ALK AXIN2	1.64e-04	268	89	6	DOID:162 (implicated_via_orthology)
Disease	endometrial adenocarcinoma (is_implicated_in)	ARID1A AXIN2	1.87e-04	7	89	2	DOID:2870 (is_implicated_in)
Disease	cortical surface area measurement	SLC38A2 MYCBP2 PIK3CD TLE4 CPEB4 SIDT1 NAV3 ROBO2 HMGCR BBS9 PMEPA1 CTSK DKK2	1.93e-04	1345	89	13	EFO_0010736
Disease	Malignant neoplasm of brain	SOX2 IDH1 ALK	2.07e-04	38	89	3	C0153633
Disease	Neoplasm Recurrence, Local	SOX2 IDH1 ALK	2.24e-04	39	89	3	C0027643
Disease	Brain Neoplasms	SOX2 IDH1 ALK	2.24e-04	39	89	3	C0006118
Disease	high grade glioma (implicated_via_orthology)	PIK3CD IDH1 WDR62	3.21e-04	44	89	3	DOID:3070 (implicated_via_orthology)
Disease	Schizophrenia	GABRD SLC38A2 PLA2G4B RANBP9 KCNQ2 NLGN2 ADNP CTSK ALK NDUFS1	3.29e-04	883	89	10	C0036341
Disease	Glioblastoma Multiforme	FOSL2 IDH1 RUNX1 CTSK	3.62e-04	111	89	4	C1621958
Disease	smoking cessation	ZBTB20 ZMIZ2 KCNQ2 ROBO2 NLGN2 PMEPA1	4.60e-04	325	89	6	EFO_0004319
Disease	response to virus	POU3F2 BBS9	4.86e-04	11	89	2	GO_0009615
Disease	Umbilical hernia	FMN1 NAV3	4.86e-04	11	89	2	HP_0001537
Disease	frontotemporal dementia (implicated_via_orthology)	TAF15 FUS	5.82e-04	12	89	2	DOID:9255 (implicated_via_orthology)
Disease	smoking behavior	GALK2 ZBTB20 DDX18 NAV3 POU3F2 SLC38A3	5.92e-04	341	89	6	EFO_0004318
Disease	T-Cell Lymphoma	ARID1A STAT5B	1.05e-03	16	89	2	C0079772
Disease	respiratory symptom change measurement, response to placebo	EBF2 BBS9	1.19e-03	17	89	2	EFO_0008344, EFO_0010068
Disease	prostate carcinoma	EBF2 ZBTB20 FMN1 SIDT1 ADNP KDSR RPA1 RFX3 CTSK	1.47e-03	891	89	9	EFO_0001663
Disease	intrahepatic cholangiocarcinoma (is_marker_for)	RUNX1 ARID1A	1.49e-03	19	89	2	DOID:4928 (is_marker_for)
Disease	lung non-small cell carcinoma (is_marker_for)	FOSL2 RUNX1 ARID1A STAT5B	1.74e-03	169	89	4	DOID:3908 (is_marker_for)
Disease	Glioblastoma	FOSL2 RUNX1 CTSK	1.78e-03	79	89	3	C0017636
Disease	Granulomatous Slack Skin	ARID1A STAT5B	2.00e-03	22	89	2	C0376407
Disease	Stomach Neoplasms	ZBTB20 TAF15 ARID1A NDUFS1 AXIN2	2.08e-03	297	89	5	C0038356
Disease	Malignant neoplasm of stomach	ZBTB20 TAF15 ARID1A NDUFS1 AXIN2	2.17e-03	300	89	5	C0024623
Disease	Lymphoma, T-Cell, Cutaneous	ARID1A STAT5B	2.18e-03	23	89	2	C0079773
Disease	hepatocellular carcinoma (is_marker_for)	FOSL2 RUNX1 ARID1A AXIN2 STAT5B	2.21e-03	301	89	5	DOID:684 (is_marker_for)
Disease	gastric carcinoma	ZBTB20 RANBP6 ALK	2.50e-03	89	89	3	EFO_0000178
Disease	Ataxia	SOX2 ADPRS	2.58e-03	25	89	2	C0004134
Disease	hair colour measurement	SLC38A2 SLC12A9 TLE4 RANBP6 ARID1A AXIN2 JPH3	2.61e-03	615	89	7	EFO_0007822
Disease	colorectal adenocarcinoma (is_marker_for)	RUNX1 STAT5B	3.01e-03	27	89	2	DOID:0050861 (is_marker_for)
Disease	Anaplastic astrocytoma	NCOA3 IDH1	3.01e-03	27	89	2	C0334579

Protein segments in the cluster

Peptide	Gene	Start	Entry
AASGLNTMLEGNGQY	TGFBI	261	Q15582
VSENDGCGGGYMTNA	CTSK	171	P43235
SVGQGYSVGQSMRLG	ADNP	336	Q9H2P0
YSVGQSMRLGLGGNA	ADNP	341	Q9H2P0
GGLGFSNTMYSRLGE	ACAD9	116	Q9H845
LSHGGGVNEYGNMGA	ADAM11	351	O75078
CSSGNGNGFRAMTGL	EBF2	556	Q9HAK2
RSGGENTAYMSNGGL	AXIN2	201	Q9Y2T1
TRATGNYAGRGTTGM	DCAF6	226	Q58WW2
TPGQAANRSAGMYQG	DKK2	46	Q9UBU2
ANRSAGMYQGLAFGG	DKK2	51	Q9UBU2
SRGGSRGARGLMNGY	CAPRIN1	611	Q14444
RDGYMGIGLSAQGVN	RANBP9	226	Q96S59
MSDSGSYGQSGGEQQ	TAF15	1	Q92804
NMESSGSQGGRAPSY	TAF15	91	Q92804
LNSYGAQASMGLSGS	RBM14	471	Q96PK6
AQASMGLSGSYGAQS	RBM14	476	Q96PK6
SGQGSYASSAIAGMV	PAX8	381	Q06710
AFGNYMNGGNRTRGQ	FMN1	1186	Q68DA7
MNGGNRTRGQADGYS	FMN1	1191	Q68DA7
GAGSSGMLNTYSLNG	INO80	86	Q9ULG1
GRAQSAMGGLSYTQQ	ARID1A	436	O14497
AGNIMNAGGYAGNAV	FHDC1	301	Q9C0D6
GVAGEDMQDNSGTYG	PRKCD	321	Q05655
NYGQDQSSMSSGGGS	FUS	176	P35637
NLVGSAMAGSIGGYN	HMGCR	736	P04035
SGGGTVYHDMGNINL	LIPT1	101	Q9Y234
YRLGSQDMQALGAGS	ASPHD1	96	Q5U4P2
SYGSFEMQAPGSGNG	EXTL2	191	Q9UBQ6
GSGNGDQYSMVLIGA	EXTL2	201	Q9UBQ6
SLSAYGGGNRASMEF	KCNQ2	751	O43526
GEMEGFNSGLNSGGS	NAV3	421	Q8IVL0
QMNLEGGGSSGGVYE	CUEDC1	86	Q9NWM3
YIGTEGGGMDQSISF	GALK2	181	Q01415
FGGRNSGSVNMGSRD	KRT24	461	Q2M2I5
SMDGTGQSYQDLRDG	LHX4	291	Q969G2
GTRAMNDIGDYVGSN	GABRD	21	O14764
SGGNMTLRCGSQKGY	LILRA6	136	Q6PI73
SGGNMTLRCGSQKGY	LILRB3	136	O75022
ATGGGIRAMTSLYGQ	PLA2G4B	301	P0C869
TYGLIMGGSNRSAEA	DDX18	281	Q9NVP1
LQRTACNMTYGSFGG	BBS9	131	Q3SYG4
NSGISATCYGSGGRM	PMEPA1	211	Q969W9
TGNMIDGSILASYGN	NLGN4Y	181	Q8NFZ3
NGSSGMGSTVSKAYG	RPA1	146	P27694
AGGSNSYRMGAEGKF	HECTD1	1316	Q9ULT8
VQSDSVAQGYGSLGM	IDH1	276	O75874
YGYGQGAGTLNMDRG	CSRP2	71	Q16527
GMAATGASGTNAVRY	LDHD	166	Q86WU2
YSSGGGGQQKFRVDM	FOSL2	26	P15408
NGGAMRVAGISLAYS	ADPRS	151	Q9NX46
GNQALYGGQMTTSAS	KLF18	271	A0A0U1RQI7
GQMTTSTGNQNLYGG	KLF18	376	A0A0U1RQI7
EQMTTSTGNQALYGG	KLF18	516	A0A0U1RQI7
STGNQALYGGQMTTS	KLF18	521	A0A0U1RQI7
GNQALYGGQMTTSAS	KLF18	621	A0A0U1RQI7
GNQALYGGQMTTSTS	KLF18	761	A0A0U1RQI7
MGDYGFGVLVQSNTG	CPEB4	1	Q17RY0
QDGSLGAGSSAMRDY	GPRIN1	31	Q7Z2K8
GNAGMAAAYAARQLG	SDS	66	P20132
GNFNSSLGSDGYMLS	KDSR	261	Q06136
GTGNMFDGSVLAAYG	NLGN2	191	Q8NFZ4
TGNMIDGSILASYGN	NLGN4X	181	Q8N0W4
ASYGQSGLVLGANMT	OTOGL	1221	Q3ZCN5
RRSMSYDNGLAQGAG	PGGT1B	201	P53609
GASAGSYQFSMVGGE	RUNX1	381	Q01196
TAGGGQNVTGLEMYT	UBOX5	71	O94941
GAGLGAGVNQRMDSY	SOX2	146	P48431
GSGILGLAYAMANTG	SLC38A3	81	Q99624
SMGRNDGVGQISGFY	AIFM2	331	Q9BRQ8
GTTGRGNDMQVGTYI	NDUFS1	196	P28331
SGGTYLIGNSMENSG	RFX3	131	P48380
QLGGSDQLGNIMSGY	YARS2	241	Q9Y2Z4
DPSTTGQMSGARYGG	NCOA3	421	Q9Y6Q9
GQMSGARYGGSSNIA	NCOA3	426	Q9Y6Q9
GQFAGQLGDGAAMYL	SELENOO	146	Q9BVL4
ADAGGGSATYMDQAP	STAT5B	716	P51692
YGSRTANGDGGMTTV	MYCBP2	1836	O75592
SNRGASQAGMTGYGR	TAGLN	181	Q01995
GMQQGAGGYREAQSL	POU3F2	26	P20265
QNSCSGMGGDGTRSI	NPAP1	1096	Q9NZP6
GLGVMAQFGGDDYRS	RANBP6	936	O60518
GSQLSAMQINSYGSG	SEC24D	121	O94855
GYIGGNAASNNDPEM	ALK	936	Q9UM73
VQTSGYQGGEQFGMD	ZBTB5	491	O15062
YQGGEQFGMDFSRSG	ZBTB5	496	O15062
LLNGSMGLSDGQGGY	SEMA4G	596	Q9NTN9
MGGATSRGENSYGLD	MTM1	96	Q13496
GMNGELTSPGAAYAG	TLE4	381	Q04727
GAGKTYTMGTGFDVN	KIF21A	91	Q7Z4S6
GSGILGLSYAMANTG	SLC38A2	86	Q96QD8
DGSFGSNDGSGNMVA	SIDT1	341	Q9NXL6
NGAVQGGGAYFMISR	SLC12A9	96	Q9BXP2
IMYSNEEAGSGGSVG	PIK3CD	761	O00329
NGVGYVLSGAGNFMD	ACP5	251	P13686
SNYAVTFQRGDGGLM	ROBO2	891	Q9HCK4
SQELSQYGAMGAGQS	ZMIZ2	176	Q8NF64
SMQNGSGERSFYSGA	ZBTB20	251	Q9HC78
MAAVGSGGYARNDAG	WDR62	1	O43379
AMENDGYGNRGAGAN	ZRANB1	591	Q9UGI0
NYFSGGRGSVQGMFA	USP54	6	Q70EL1
GLNHNYGNAVTGGGM	TRERF1	31	Q96PN7
YGNAVTGGGMDAPQA	TRERF1	36	Q96PN7
STVGTLYAVGGMDNN	KLHL1	456	Q9NR64
MSSGGRFNFDDGGSY	JPH3	1	Q8WXH2